{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T11:57:04Z","timestamp":1781265424863,"version":"3.54.1"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T00:00:00Z","timestamp":1775520000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T00:00:00Z","timestamp":1775520000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Intern Emerg Med"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1007\/s11739-026-04345-7","type":"journal-article","created":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T15:12:53Z","timestamp":1775574773000},"page":"1441-1450","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Impact of vitamin D plasma levels on in vitro natural killer cell cytotoxicity against non-small cell lung carcinoma in the presence of nivolumab"],"prefix":"10.1007","volume":"21","author":[{"given":"Federica","family":"Randisi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sahar","family":"Balkhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenzo","family":"Mortara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuela","family":"Marras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Molteni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Epis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Di Spirito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgia","family":"Bilato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raffaella","family":"Bombelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Dentali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5683-0885","authenticated-orcid":false,"given":"Marzia Bruna","family":"Gariboldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonardo","family":"Campiotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,7]]},"reference":[{"key":"4345_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.canep.2024.102693","author":"J Zhou","year":"2024","unstructured":"Zhou J, Xu Y, Liu J, Feng L, Yu J, Chen D (2024) Global burden of lung cancer in 2022 and projections to 2050: incidence and mortality estimates from GLOBOCAN. Cancer Epidemiol. https:\/\/doi.org\/10.1016\/j.canep.2024.102693","journal-title":"Cancer Epidemiol"},{"key":"4345_CR2","doi-asserted-by":"crossref","unstructured":"Li C, Lei S, Ding L, Xu Y, Wu X, Wang H, et al. Global burden and trends of lung cancer incidence and mortality. Chin Med J (Engl). 2023;136.","DOI":"10.21203\/rs.3.rs-1246650\/v1"},{"key":"4345_CR3","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15143710","author":"G Vicidomini","year":"2023","unstructured":"Vicidomini G (2023) Current challenges and future advances in lung cancer: genetics, instrumental diagnosis and treatment. Cancers. https:\/\/doi.org\/10.3390\/cancers15143710","journal-title":"Cancers"},{"key":"4345_CR4","doi-asserted-by":"publisher","DOI":"10.1200\/CCI-24-00291","volume":"9","author":"H Dai","year":"2025","unstructured":"Dai H, Huang Y, He X, Zhou T, Liu Y, Zhang X et al (2025) Optimizing Strategy for Lung Cancer Screening: From Risk Prediction to Clinical Decision Support. JCO Clin cancer informatics 9:e2400291","journal-title":"JCO Clin cancer informatics"},{"key":"4345_CR5","doi-asserted-by":"crossref","unstructured":"M N, G B, Sharma M. Personalized approaches to lung cancer treatment: A review of targeted therapies, pharmacogenomics, and combination strategies. Asp Mol Med. 2025;5.","DOI":"10.1016\/j.amolm.2025.100073"},{"key":"4345_CR6","doi-asserted-by":"publisher","DOI":"10.1038\/s41568-018-0081-9","author":"NK Altorki","year":"2019","unstructured":"Altorki NK, Markowitz GJ, Gao D, Port JL, Saxena A, Stiles B et al (2019) The lung microenvironment: an important regulator of tumour growth and metastasis. Nat Rev Cancer. https:\/\/doi.org\/10.1038\/s41568-018-0081-9","journal-title":"Nat Rev Cancer"},{"key":"4345_CR7","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1301317","author":"A-P Ganesan","year":"2013","unstructured":"Ganesan A-P, Johansson M, Ruffell B, Beltran A, Lau J, Jablons DM et al (2013) Tumor-infiltrating regulatory T Cells inhibit endogenous cytotoxic T Cell responses to lung adenocarcinoma. J Immunol. https:\/\/doi.org\/10.4049\/jimmunol.1301317","journal-title":"J Immunol"},{"key":"4345_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jncc.2022.10.002","author":"F Wang","year":"2022","unstructured":"Wang F, Yang M, Luo W, Zhou Q (2022) Characteristics of tumor microenvironment and novel immunotherapeutic strategies for non-small cell lung cancer. Journal of the National Cancer Center. https:\/\/doi.org\/10.1016\/j.jncc.2022.10.002","journal-title":"Journal of the National Cancer Center"},{"key":"4345_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2023.02.016","author":"KE de Visser","year":"2023","unstructured":"de Visser KE, Joyce JA (2023) The evolving tumor microenvironment: from cancer initiation to metastatic outgrowth. Cancer Cell. https:\/\/doi.org\/10.1016\/j.ccell.2023.02.016","journal-title":"Cancer Cell"},{"key":"4345_CR10","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.914890","author":"D Baci","year":"2022","unstructured":"Baci D, Cekani E, Imperatori A, Ribatti D, Mortara L (2022) Host-related factors as targetable drivers of immunotherapy response in non-small cell lung cancer patients. Front Immunol. https:\/\/doi.org\/10.3389\/fimmu.2022.914890","journal-title":"Front Immunol"},{"key":"4345_CR11","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.799455","author":"C Genova","year":"2022","unstructured":"Genova C, Dellepiane C, Carrega P, Sommariva S, Ferlazzo G, Pronzato P et al (2022) Therapeutic implications of tumor microenvironment in lung cancer: focus on immune checkpoint blockade. Front Immunol. https:\/\/doi.org\/10.3389\/fimmu.2021.799455","journal-title":"Front Immunol"},{"key":"4345_CR12","doi-asserted-by":"publisher","DOI":"10.1038\/ni1582","author":"E Vivier","year":"2008","unstructured":"Vivier E, Tomasello E, Baratin M, Walzer T, Ugolini S (2008) Functions of natural killer cells. Nat Immunol. https:\/\/doi.org\/10.1038\/ni1582","journal-title":"Nat Immunol"},{"key":"4345_CR13","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-023-06945-1","author":"E Vivier","year":"2024","unstructured":"Vivier E, Rebuffet L, Narni-Mancinelli E, Cornen S, Igarashi RY, Fantin VR (2024) Natural killer cell therapies. Nature. https:\/\/doi.org\/10.1038\/s41586-023-06945-1","journal-title":"Nature"},{"key":"4345_CR14","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.03038","author":"O Melaiu","year":"2020","unstructured":"Melaiu O, Lucarini V, Cifaldi L, Fruci D (2020) Influence of the tumor microenvironment on NK cell function in solid tumors. Front Immunol. https:\/\/doi.org\/10.3389\/fimmu.2019.03038","journal-title":"Front Immunol"},{"key":"4345_CR15","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/6248590","author":"B Han","year":"2018","unstructured":"Han B, Mao FY, Zhao YL, Lv YP, Teng YS, Duan M et al (2018) Altered NKp30, NKp46, NKG2D, and DNAM-1 expression on circulating NK cells is associated with tumor progression in human gastric cancer. J Immunol Res. https:\/\/doi.org\/10.1155\/2018\/6248590","journal-title":"J Immunol Res"},{"key":"4345_CR16","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-023-01737-7","author":"Y Zhou","year":"2023","unstructured":"Zhou Y, Cheng L, Liu L, Li X (2023) NK cells are never alone: crosstalk and communication in tumour microenvironments. Mol Cancer. https:\/\/doi.org\/10.1186\/s12943-023-01737-7","journal-title":"Mol Cancer"},{"key":"4345_CR17","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.23239","author":"P Carrega","year":"2008","unstructured":"Carrega P, Morandi B, Costa R, Frumento G, Forte G, Altavilla G et al (2008) Natural killer cells infiltrating human nonsmall-cell lung cancer are enriched in CD56brightCD16- cells and display an impaired capability to kill tumor cells. Cancer. https:\/\/doi.org\/10.1002\/cncr.23239","journal-title":"Cancer"},{"key":"4345_CR18","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-10-4179","author":"S Platonova","year":"2011","unstructured":"Platonova S, Cherfils-Vicini J, Damotte D, Crozet L, Vieillard V, Validire P et al (2011) Profound coordinated alterations of intratumoral NK cell phenotype and function in lung carcinoma. Cancer Res. https:\/\/doi.org\/10.1158\/0008-5472.CAN-10-4179","journal-title":"Cancer Res"},{"key":"4345_CR19","doi-asserted-by":"publisher","DOI":"10.1593\/neo.121758","author":"A Bruno","year":"2013","unstructured":"Bruno A, Focaccetti C, Pagani A, Imperatori AS, Spagnoletti M, Rotolo N et al (2013) The proangiogenic phenotype of natural killer cells in patients with non-small cell lung cancer. Neoplasia. https:\/\/doi.org\/10.1593\/neo.121758","journal-title":"Neoplasia"},{"key":"4345_CR20","doi-asserted-by":"publisher","DOI":"10.3892\/or.2021.8183","author":"Y Zeng","year":"2021","unstructured":"Zeng Y, Lv X, Du J (2021) Natural killer cell-based immunotherapy for lung cancer: challenges and perspectives (Review). Oncol Rep. https:\/\/doi.org\/10.3892\/or.2021.8183","journal-title":"Oncol Rep"},{"key":"4345_CR21","doi-asserted-by":"publisher","DOI":"10.5582\/irdr.2017.01059","author":"X Zheng","year":"2017","unstructured":"Zheng X, Hu Y, Yao C (2017) The paradoxical role of tumor-infiltrating immune cells in lung cancer. Intract Rare Dis Res. https:\/\/doi.org\/10.5582\/irdr.2017.01059","journal-title":"Intract Rare Dis Res"},{"key":"4345_CR22","unstructured":"Han Y, Liu D, Li L. PD-1\/PD-L1 pathway: current researches in cancer. Am J Cancer Res. 2020;10."},{"key":"4345_CR23","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.948405","author":"O Mussafi","year":"2022","unstructured":"Mussafi O, Mei J, Mao W, Wan Y (2022) Immune checkpoint inhibitors for PD-1\/PD-L1 axis in combination with other immunotherapies and targeted therapies for non-small cell lung cancer. Front Oncol. https:\/\/doi.org\/10.3389\/fonc.2022.948405","journal-title":"Front Oncol"},{"key":"4345_CR24","doi-asserted-by":"publisher","DOI":"10.2217\/fon-2015-0012","author":"M Reck","year":"2016","unstructured":"Reck M, Heigener D, Reinmuth N (2016) Immunotherapy for small-cell lung cancer: emerging evidence. Future Oncol. https:\/\/doi.org\/10.2217\/fon-2015-0012","journal-title":"Future Oncol"},{"key":"4345_CR25","doi-asserted-by":"publisher","DOI":"10.3390\/curroncol30020181","author":"M Russano","year":"2023","unstructured":"Russano M, La Cava G, Cortellini A, Citarella F, Galletti A, Di Fazio GR et al (2023) Immunotherapy for metastatic non-small cell lung cancer: therapeutic advances and biomarkers. Curr Oncol. https:\/\/doi.org\/10.3390\/curroncol30020181","journal-title":"Curr Oncol"},{"key":"4345_CR26","unstructured":"Wang X, Teng F, Kong L, Yu J. PD-L1 expression in human cancers and its association with clinical outcomes. Onco. Targets. Ther. 2016."},{"key":"4345_CR27","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2015-0507","author":"D Kazandjian","year":"2016","unstructured":"Kazandjian D, Suzman DL, Blumenthal G, Mushti S, He K, Libeg M et al (2016) FDA approval summary: Nivolumab for the treatment of metastatic non-small cell lung cancer with progression on or after platinum-based chemotherapy. Oncologist. https:\/\/doi.org\/10.1634\/theoncologist.2015-0507","journal-title":"Oncologist"},{"key":"4345_CR28","doi-asserted-by":"crossref","unstructured":"Dang TO, Ogunniyi A, Barbee MS, Drilon A. Pembrolizumab for the treatment of PD-L1 positive advanced or metastatic non-small cell lung cancer. Expert Rev Anticancer Ther. 2016;16.","DOI":"10.1586\/14737140.2016.1123626"},{"key":"4345_CR29","doi-asserted-by":"publisher","DOI":"10.21037\/tlcr.2017.05.09","author":"C Gridelli","year":"2017","unstructured":"Gridelli C, Ardizzoni A, Barberis M, Cappuzzo F, Casaluce F, Danesi R et al (2017) Predictive biomarkers of immunotherapy for non-small cell lung cancer: results from an experts panel meeting of the Italian Association of Thoracic Oncology. Transl Lung Cancer Res. https:\/\/doi.org\/10.21037\/tlcr.2017.05.09","journal-title":"Transl Lung Cancer Res"},{"key":"4345_CR30","doi-asserted-by":"crossref","unstructured":"Stucci LS, D\u2019Oronzo S, Tucci M, Macerollo A, Ribero S, Spagnolo F, et al. Vitamin D in melanoma: Controversies and potential role in combination with immune check-point inhibitors. Cancer Treat. Rev. 2018.","DOI":"10.1016\/j.ctrv.2018.05.016"},{"key":"4345_CR31","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1126\/science.adh7954","volume":"384","author":"E Giampazolias","year":"2024","unstructured":"Giampazolias E, Costa MPD, Lam KC, Lim KHJ, Cardoso A, Piot C et al (2024) Vitamin D regulates microbiome-dependent cancer immunity. Science 384:428\u2013437","journal-title":"Science"},{"key":"4345_CR32","doi-asserted-by":"publisher","DOI":"10.1007\/s11739-018-1957-0","author":"L Campiotti","year":"2018","unstructured":"Campiotti L, Bolzacchini E, Sutter MB, Maresca AM, Grandi AM, Guasti L (2018) Vitamin D and tyrosine kinase inhibitors in chronic myeloid leukemia. Intern Emerg Med. https:\/\/doi.org\/10.1007\/s11739-018-1957-0","journal-title":"Intern Emerg Med"},{"key":"4345_CR33","doi-asserted-by":"publisher","DOI":"10.1007\/s11523-018-0586-x","author":"L Mortara","year":"2018","unstructured":"Mortara L, Gariboldi MB, Bosi A, Bregni M, Pinotti G, Guasti L et al (2018) Vitamin D deficiency has a negative impact on Cetuximab-mediated cellular cytotoxicity against human colon carcinoma cells. Target Oncol. https:\/\/doi.org\/10.1007\/s11523-018-0586-x","journal-title":"Target Oncol"},{"key":"4345_CR34","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.3694","author":"S Rezasoltani","year":"2021","unstructured":"Rezasoltani S, Yadegar A, Asadzadeh Aghdaei H, Reza Zali M (2021) Modulatory effects of gut microbiome in cancer immunotherapy: a novel paradigm for blockade of immune checkpoint inhibitors. Cancer Med. https:\/\/doi.org\/10.1002\/cam4.3694","journal-title":"Cancer Med"},{"key":"4345_CR35","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.34718","author":"\u0141 Galus","year":"2023","unstructured":"Galus \u0141, Michalak M, Lorenz M, Stoi\u0144ska-Swiniarek R, Tusie\u0144 Ma\u0142ecka D, Galus A et al (2023) Vitamin D supplementation increases objective response rate and prolongs progression-free time in patients with advanced melanoma undergoing anti\u2013PD-1 therapy. Cancer. https:\/\/doi.org\/10.1002\/cncr.34718","journal-title":"Cancer"},{"key":"4345_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.bulcan.2017.05.001","author":"J-D Huang","year":"2017","unstructured":"Huang J-D, Dong C-H, Shao S-W, Gu T-J, Hu Z-L, Ying J et al (2017) Circulating 25-hydroxyvitamin D level and prognosis of lung cancer patients: a systematic review and meta-analysis. Bull Cancer. https:\/\/doi.org\/10.1016\/j.bulcan.2017.05.001","journal-title":"Bull Cancer"},{"key":"4345_CR37","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.18766","author":"J Liu","year":"2017","unstructured":"Liu J, Dong Y, Lu C, Wang Y, Peng L, Jiang M et al (2017) Meta-analysis of the correlation between vitamin D and lung cancer risk and outcomes. Oncotarget. https:\/\/doi.org\/10.18632\/oncotarget.18766","journal-title":"Oncotarget"},{"key":"4345_CR38","doi-asserted-by":"publisher","DOI":"10.3390\/cancers11010125","author":"J Cusato","year":"2019","unstructured":"Cusato J, Genova C, Tomasello C, Carrega P, Ottonello S, Pietra G et al (2019) Influence of Vitamin D in advanced non-small cell lung cancer patients treated with Nivolumab. Cancers (Basel). https:\/\/doi.org\/10.3390\/cancers11010125","journal-title":"Cancers (Basel)"},{"key":"4345_CR39","doi-asserted-by":"publisher","DOI":"10.1097\/JTO.0000000000000500","author":"N Chen","year":"2015","unstructured":"Chen N, Fang W, Zhan J, Hong S, Tang Y, Kang S et al (2015) Upregulation of PD-L1 by EGFR activation mediates the immune escape in EGFR-driven NSCLC: implication for optional immune targeted therapy for NSCLC patients with EGFR mutation. J Thorac Oncol. https:\/\/doi.org\/10.1097\/JTO.0000000000000500","journal-title":"J Thorac Oncol"},{"key":"4345_CR40","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.canlet.2015.05.008","volume":"364","author":"MB Gariboldi","year":"2015","unstructured":"Gariboldi MB, Taiana E, Bonzi MC, Craparotta I, Giovannardi S, Mancini M et al (2015) The BH3-mimetic obatoclax reduces HIF-1\u03b1 levels and HIF-1 transcriptional activity and sensitizes hypoxic colon adenocarcinoma cells to 5-fluorouracil. Cancer Lett 364:156\u2013164","journal-title":"Cancer Lett"},{"key":"4345_CR41","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-10-340","author":"R Mar\u00e9chal","year":"2010","unstructured":"Mar\u00e9chal R, De Schutter J, Nagy N, Demetter P, Lemmers A, Devi\u00e8re J et al (2010) Putative contribution of CD56 positive cells in Cetuximab treatment efficacy in first-line metastatic colorectal cancer patients. BMC Cancer. https:\/\/doi.org\/10.1186\/1471-2407-10-340","journal-title":"BMC Cancer"},{"key":"4345_CR42","doi-asserted-by":"publisher","DOI":"10.1111\/j.1349-7006.2002.tb01293.x","author":"I Naruse","year":"2002","unstructured":"Naruse I, Fukumoto H, Saijo N, Nishio K (2002) Enhanced anti-tumor effect of Trastuzumab in combination with Cisplatin. Jpn J Cancer Res. https:\/\/doi.org\/10.1111\/j.1349-7006.2002.tb01293.x","journal-title":"Jpn J Cancer Res"},{"key":"4345_CR43","doi-asserted-by":"publisher","DOI":"10.1155\/2023\/6597730","author":"MA Majid","year":"2023","unstructured":"Majid MA, Hassan WN, Ridha AF (2023) Prevalence of 25-Hydroxyvitamin D (Vitamin D) deficiency in a group of infertile women from Baghdad City. Biochem Res Int. https:\/\/doi.org\/10.1155\/2023\/6597730","journal-title":"Biochem Res Int"},{"key":"4345_CR44","doi-asserted-by":"publisher","DOI":"10.1038\/s41430-020-0558-y","author":"K Amrein","year":"2020","unstructured":"Amrein K, Scherkl M, Hoffmann M, Neuwersch-Sommeregger S, K\u00f6stenberger M, Tmava Berisha A et al (2020) Vitamin D deficiency 2.0: an update on the current status worldwide. Eur J Clin Nutr. https:\/\/doi.org\/10.1038\/s41430-020-0558-y","journal-title":"Eur J Clin Nutr"},{"key":"4345_CR45","doi-asserted-by":"publisher","DOI":"10.1038\/s41389-020-00257-z","author":"M Liu","year":"2020","unstructured":"Liu M, Wang X, Li W, Yu X, Flores-Villanueva P, Xu-Monette ZY et al (2020) Targeting PD-L1 in non-small cell lung cancer using CAR T cells. Oncogenesis. https:\/\/doi.org\/10.1038\/s41389-020-00257-z","journal-title":"Oncogenesis"},{"key":"4345_CR46","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-020-2701-z","author":"W Yu","year":"2020","unstructured":"Yu W, Hua Y, Qiu H, Hao J, Zou K, Li Z et al (2020) PD-L1 promotes tumor growth and progression by activating WIP and \u03b2-catenin signaling pathways and predicts poor prognosis in lung cancer. Cell Death Dis. https:\/\/doi.org\/10.1038\/s41419-020-2701-z","journal-title":"Cell Death Dis"},{"key":"4345_CR47","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-018-2188-y","author":"VI Segatori","year":"2018","unstructured":"Segatori VI, Cuello HA, Gulino CA, Albert\u00f3 M, Venier C, Guthmann MD et al (2018) Antibody-dependent cell-mediated cytotoxicity induced by active immunotherapy based on racotumomab in non-small cell lung cancer patients. Cancer Immunol Immunother. https:\/\/doi.org\/10.1007\/s00262-018-2188-y","journal-title":"Cancer Immunol Immunother"},{"key":"4345_CR48","doi-asserted-by":"crossref","unstructured":"Broussas M, Broyer L, Goetsch L. Evaluation of antibody-dependent cell cytotoxicity using lactate dehydrogenase (LDH) measurement. Methods Mol Biol. 2013;988.","DOI":"10.1007\/978-1-62703-327-5_19"},{"key":"4345_CR49","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.950465","author":"A Ghaseminejad-Raeini","year":"2023","unstructured":"Ghaseminejad-Raeini A, Ghaderi A, Sharafi A, Nematollahi-Sani B, Moossavi M, Derakhshani A et al (2023) Immunomodulatory actions of vitamin D in various immune-related disorders: a comprehensive review. Front Immunol. https:\/\/doi.org\/10.3389\/fimmu.2023.950465","journal-title":"Front Immunol"},{"key":"4345_CR50","doi-asserted-by":"publisher","DOI":"10.3390\/nu12051248","author":"PJ Martens","year":"2020","unstructured":"Martens PJ, Gysemans C, Verstuyf A, Mathieu C (2020) Vitamin D\u2019s effect on immune function. Nutrients. https:\/\/doi.org\/10.3390\/nu12051248","journal-title":"Nutrients"},{"key":"4345_CR51","doi-asserted-by":"publisher","DOI":"10.3390\/nu15163498","author":"K Christofyllakis","year":"2023","unstructured":"Christofyllakis K, Neumann F, Bewarder M, Thurner L, Kaddu-Mulindwa D, Kos IA et al (2023) Vitamin D enhances immune effector pathways of NK cells thus providing a mechanistic explanation for the increased effectiveness of therapeutic monoclonal antibodies. Nutrients. https:\/\/doi.org\/10.3390\/nu15163498","journal-title":"Nutrients"},{"key":"4345_CR52","doi-asserted-by":"publisher","DOI":"10.1002\/eji.201545541","author":"K Ota","year":"2015","unstructured":"Ota K, Dambaeva S, Kim MWI, Han AR, Fukui A, Gilman-Sachs A et al (2015) 1,25-Dihydroxy-vitamin D3 regulates NK-cell cytotoxicity, cytokine secretion, and degranulation in women with recurrent pregnancy losses. Eur J Immunol. https:\/\/doi.org\/10.1002\/eji.201545541","journal-title":"Eur J Immunol"},{"key":"4345_CR53","doi-asserted-by":"publisher","DOI":"10.1017\/S0007114522000149","author":"A Wierzbicka","year":"2022","unstructured":"Wierzbicka A, Oczkowicz M (2022) Sex differences in vitamin D metabolism, serum levels and action. Br J Nutr. https:\/\/doi.org\/10.1017\/S0007114522000149","journal-title":"Br J Nutr"},{"key":"4345_CR54","doi-asserted-by":"publisher","DOI":"10.3390\/nu5072502","author":"B Prietl","year":"2013","unstructured":"Prietl B, Treiber G, Pieber TR, Amrein K (2013) Vitamin D and immune function. Nutrients. https:\/\/doi.org\/10.3390\/nu5072502","journal-title":"Nutrients"},{"key":"4345_CR55","doi-asserted-by":"publisher","DOI":"10.1111\/nyas.12443","author":"P Lips","year":"2014","unstructured":"Lips P, van Schoor NM, de Jongh RT (2014) Diet, sun, and lifestyle as determinants of vitamin D status. Ann N Y Acad Sci. https:\/\/doi.org\/10.1111\/nyas.12443","journal-title":"Ann N Y Acad Sci"},{"key":"4345_CR56","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1097\/CJI.0000000000000500","volume":"47","author":"KG Akers","year":"2024","unstructured":"Akers KG, Oskar S, Zhao B, Frederickson AM, Arunachalam A (2024) Clinical outcomes of PD-1\/PD-L1 inhibitors among patients with advanced or metastatic non-small cell lung cancer with BRAF, ERBB2\/HER2, MET, or RET alterations: A systematic literature review. J Immunother 47:128\u2013138","journal-title":"J Immunother"},{"key":"4345_CR57","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2021-002891","author":"MV Negr\u00e3o","year":"2021","unstructured":"Negr\u00e3o MV, Skoulidis F, Montesion M, Schulze K, B\u0101ra I, Shen V et al (2021) Oncogene-specific differences in tumor mutational burden, PD-L1 expression, and outcomes from immunotherapy in non-small cell lung cancer. J Immunother Cancer. https:\/\/doi.org\/10.1136\/jitc-2021-002891","journal-title":"J Immunother Cancer"}],"container-title":["Internal and Emergency Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11739-026-04345-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11739-026-04345-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11739-026-04345-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T11:07:18Z","timestamp":1781262438000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11739-026-04345-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,7]]},"references-count":57,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["4345"],"URL":"https:\/\/doi.org\/10.1007\/s11739-026-04345-7","relation":{},"ISSN":["1828-0447","1970-9366"],"issn-type":[{"value":"1828-0447","type":"print"},{"value":"1970-9366","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,7]]},"assertion":[{"value":"5 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Ethical approval was obtained from Insubria Provincial Ethical Committee (protocol n.1126).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}